2014 Press Releases
Chancellor Michael F. Collins issued the following statement on the announced departure of University of Massachusetts President Robert Caret.
Phillip D. Zamore, PhD, a pioneer in the study of RNA silencing, was named a 2014 Fellow of the National Academy of Inventors, a high professional distinction accorded to academic inventors who have demonstrated a prolific spirit of innovation.
MassBiologics of UMass Medical School and Voyager Therapeutics will collaborate on viral vector manufacturing at the new MassBiologics SouthCoast facility in Fall River.
Two newly endowed chairs were approved by the university’s Board of Trustees, according to Chancellor Michael F. Collins. Katherine F. Ruiz de Luzuriaga, MD, was named the inaugural recipient of the UMass Memorial Health Care Chair in Biomedical Research. Gyongyi Szabo, MD, PhD, was named the inaugural recipient of the second Worcester Foundation for Biomedical Research Chair.
UMass Medical School is leading an initiative to restore critically needed basic health care in Liberia by re-opening hospitals overwhelmed by Ebola outbreaks, thanks to funding from the Paul G. Allen Family Foundation.
Brendan O’Leary, PhD, an accomplished scientist and venture capitalist specializing in the pharmaceutical, medical device and diagnostic sectors, will join UMass Medical School as an executive vice chancellor responsible for promoting innovation and business development, according to Chancellor Michael F. Collins.
Otherwise healthy patients who have mild hypertension are being overtreated, according to an analysis published in The BMJ by UMass Medical School family physicians Stephen Martin, MD, and Marcy Boucher, MD.
The Meyers Primary Care Institute at UMass Medical School is one of 10 sites taking part in a $30 million, five-year intervention study to drastically reduce the number of falls in older adults funded by National Institutes of Health and the Patient Centered Outcomes Research Institute.
The Center for Collaborative Research in Fragile X at UMMS, with a $9.5 million NIH grant, will be led by Professor of Molecular Medicine Joel D. Richter, PhD. Fragile X is the most common form of inherited intellectual and developmental disability. It can affect one in about 4,000 males and one in about 6,000 females.
UMass Medical School, the Patrick administration and the Veterans Administration announced plans for a new outpatient clinic for veterans care on the UMMS campus in Worcester.